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 INTRODUCTION 
 Burkholderia pseudomallei infections are an important 
cause of systemic pyogenic disease associated with high mor-
tality 1 in South East Asia and Northern Australia. In the last 
two decades, however, there have been increasing reports of 
confirmed autochthonous acquired cases and small outbreaks 
in America (especially Brazil) 2, 3 and some African countries. 4 
Melioidosis occasionally presents in case clusters related to 
extreme weather events or environmental contamination. In 
fact, the incidence of the disease increased after the 2004 tsu-
nami in Indonesia because of the massive contact of humans 
with surface waters. 1 Some experts suggest that climate change 
could modify the distribution and prevalence of this disease. 3 
We report here what seems to be the first case of imported 
melioidosis in Spain. 
 THE CLINICAL CASE 
 A 29-year-old Gambian man was attended in our hospital 
in October 2009 with a month-long history of fever and pain 
in the legs. The patient immigrated to Spain 4 years previously 
and in February 2009 was diagnosed with an autoimmune hep-
atitis that was treated with prednisone. The patient developed 
hyperglycemia requiring insulin. 
 From May to September 2009 he visited Gambia and during 
the month of June he traveled from there to Guinea-Bissau, 
also spending some days in Dakar (Senegal). In the weeks pre-
vious to the admission, he noted swelling and pain in both legs 
and developed fever and a productive cough. On examination, 
he appeared emaciated and his temperature was 38°C, and 
coarse crackles were heard in the left lower lobe of his chest. 
The patient’s calves were swollen and painful and no signs of 
trauma, erythema, or warmth were present. No other physi-
cal signs or symptoms were observed. Laboratory evaluation 
showed a white blood cell count of 16,300 cells/mm 3 (93% 
polymorphonuclear leukocytes). The biochemical tests, includ-
ing liver enzymes, were normal except for hyperglycemia. 
 X-rays and computed tomography scans of chest and 
abdomen showed images consistent with septic embolism in 
the spleen, an infiltrate in the left lower lobe and an ipsilat-
eral pleural effusion. A magnetic resonance imaging of both 
legs revealed images suggesting pyomyositis with abscess of 
12 × 6 cm in the muscles of the right leg and 6 × 4 cm in the 
left ( Figure 1 ). Aspiration and surgical drainage were per-
formed the day of admission without complications. 
 The patient initially received ceftazidime, ciprofloxacin, and 
vancomycin and once the results of cultures and antibiotic sus-
ceptibility testing were available, the treatment was changed to 
ceftazidime 50 mg/kg/6 h and sulfamethoxazole-trimethoprim 
1,600/320 mg/12 h. The microorganism was sensitive to ceftazi-
dime, cefepime, amoxicillin/clavulanate, piperacillin, piperacil-
lin/tazobactam, and chloramphenicol. 
 The intravenous treatment was administered for 5 weeks 
and was changed afterward to doxycycline and sulfamethox-
azole-trimethoprim for 20 weeks. The clinical and radiological 
evolution was excellent and no residual signs were detected 
when the patient was discharged from the hospital 
 ISOLATION, IDENTIFICATION, AND 
CHARACTERIZATION OF  B. PSEUDOMALLEI 
 Culture from the pus aspirated from the calf and several 
sputums of the patient produced a pseudomonal-like microor-
ganism that was biochemically identified initially by an auto-
mated system (VITEK II; bioMérieux, Marcy-l’Etoile, France) 
as  Burkholderia cepacia . Because of the rarity of the finding in 
our context, further identification tests were performed (API 
20 NE; bioMérieux ), that indicated, in combination with the 
susceptibility pattern of the strain, that we had isolated a strain 
of  B. pseudomallei (API 20 NE bioquemical test identification 
profile: 1156576, 99.9% of identification certainty). All myco-
bacterial and fungal cultures performed in the specimens were 
negative. 
 A multiplex polymerase chain reaction (PCR) combined 
with reverse line blot was designed for  Burkholderia spe-
cies-detection using specific targets previously described for 
 B. pseudomallei ( orf1 1),  B. mallei ( bimA ), and  Burkholderia 
thailandensis ( BpSCU2 ). 5 Primers and probes used in this assay 
are shown in  Table 1 . The method was capable of detecting up 
to 10 genome equivalents of  B. pseudomallei ( Figure 2 , panel A, 
lanes 1–4) and differentiated this species from  B. mallei and 
 B. thailandensis ( Figure 2 , panel A, lanes 5–6). Moreover, the 
method showed a good specificity as no hybridization signals 
were obtained with close species like  Burkholderia cepacia 
and  Burkholderia vietnamiensis. The strain isolated from the 
patient (BpSp1) was confirmed as  B. pseudomallei by spe-
cific hybridization with the probe P-Bps ( Figure 2 , panel A, 
lanes 13–14). The blood sample from the patient, however, was 
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negative  ( Figure 2 , panel A, lane 11), indicating no circulation 
of this pathogen in the blood at that stage of the disease. 
 The strain was further characterized by multilocus sequence 
typing (MLST) as described previously 6 and the obtained 
sequence type (ST) was compared with the public data-
base ( http://bpseudomallei.mlst.net/ ). The identified ST was 
349 (1-1-13-2-6-1-1). Interestingly, only one strain, isolated 
in Martinique, shared this ST in the database. The analysis 
by eBURST (hosted at the Imperial College, London, UK) 
grouped this ST in the main clonal complex of  B. pseudomallei 
into the subgroup founder 10 ( Figure 2 , panel B). Moreover, 
the ST 349 showed only two single locus variants [ST 12 
(Ecuador) and ST 518 (USA)] indicating a closer relationship 
with these American STs rather than with others from Africa. 
 DISCUSSION 
 Although sporadic cases of melioidosis have been reported 
in West and East Africa and, more recently, in Madagascar 
and Mauritius, 5 the extent and relevance of this disease in 
the continent remains largely unknown, due probably to the 
absence of bacteriological diagnostic resources, 7 the overlap-
ping of the clinical disease caused by  B. pseudomallei with 
other pyogenic infections, such as tuberculosis, 3 and a lack of 
awareness of the disease among clinicians. From Gambia, only 
one previous case report has been published until now. 8 Our 
patient traveled from Gambia to Guinea-Bissau for a month 
and also spent a few days in Dakar (Senegal); however, he was 
in Gambia (Sambaya) when the rainy season started and was 
probably infected there, because it is widely recognized that 
many patients in endemic countries are infected in the first 
week of the rainy season. 7 
 Figure 1.  Bilateral calf abscess caused by  Burkholderia pseudo-
mallei (NMR). 
 Table 1 
 Primers and probes used in the  Burkholderia multiplex polymerase chain reaction (PCR) combined with reverse line blot (RLB) 
Target * Oligo Sequence † Reference
 Orf1 1 
 B. pseudomallei 
HORF11FBIO 5¢-bio-ATCGCCAAATGCCGGGTTTCGGC This study
HORF11RBIO 5¢-bio-CAAATGGCCATCGTGATGTTCGG This study
P-Bps 5¢-a- TCGGCGAACGCGATTTGATCGTTC  5 
 bimA 
B. mallei 
BIO-BimA68 5¢-bio-GCGGAGCGATGGACGAAC This study
BIO-BimA216 5¢-bio-CGCCAGTTGATTCTCCCACC This study
P-Bma 5¢-a-CATACGGATGTATAGAACCAAT  11 
BpSCU2 
 B. thailandensis 
HSCU2FBIO 5¢-bio-CTCGAGCTCGTGAAGATGATCG This study
HSCU2RBIO 5¢-bio-ACGCGTGCGATCTTGTAATCGG This study
P-Bth 5¢-a-CTGTTTCCGCTCGTCGTCG This study
 *  Specific target for each pathogen. BpSCU2 is present in the three species; the probe P-Bth is specific for  Burkholderia thailandensis . 
 †  Primers were modified with biotin (bio) and probes with amino (a) at the 5¢. 
 Figure 2.  Panel  A :  Burkholderia multiplex polymerase chain 
reaction (PCR) combined with reverse line blot (RLB). Lane 1–4: 
 Burkholderia pseudomallei strain NCTC 11642 10 4 , 10 3 , 10 2 , and 10 
genomic equivalent (GE), respectively; 5:  Burkholderia mallei NCTC 
10245 10 4 GE; 6:  Burkholderia thailandensis CCUG 48851 10 4 GE; 7: 
 Burkholderia vietnamiensis CCUG 34170 10 4 GE; 8–9:  Burkholderia 
cepacia 1,614/09 and 1,675/09 (Spanish patients) 10 4 GE, respectively; 
10: DNA Extraction control; 11: 100 ng of blood sample DNA from 
the patient; 12: PCR negative control (water); 13–14: strain BpSp1 
10 6 and 10 4 GE. Probes are indicated on the left. P-Bma: probe 
specific for  B. mallei , P-Bps: specific for  B. pseudomallei , and P-Bth: 
specific for  B. thailandensis. Panel  B : Fragment of the main complex 
of  B. pseudomallei , obtained with the eBURST software, showing the 
subgroup founder ST 10 (Thailand) and its relationships with other 
STs. Geographic regions where strains of these ST were isolated are 
indicated between brackets. Arrows show single locus variants (only 
one locus different in the MLST pattern) of ST 349. The size of the 
dots represents the number of isolates of each ST available in the 
MLST database. 
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 The identification of  B. pseudomallei can be elusive, even 
in developed countries, as widely used automated identifica-
tion systems, such as (Phoenix; BD Diagnostic Systems, Sparks, 
MD) or VITEK 2, 1 normally confound this bacterium with 
 B. cepacia , a common respiratory pathogen commonly found 
in cystic fibrosis patients and lung nosocomial infections. The 
API 20 NE system is usually more accurate in the bacterial 
identification, 9 and in one study 35 from 58 isolates were cor-
rectly identified. 1 One clear problem is the lack of awareness 
of this disease in patients coming from non-endemic areas. In 
such cases, only a high index of clinical and microbiological 
suspicion can help in identifying such an isolate. For instance, 
the identification of a  Burkholderia spp. with an unusual 
pattern of antibiotic susceptibility (sensitive to amoxicillin/
clavulanate) or a characteristic fenotipe (wrinkled lactose-
positive colonies) of old cultures in MacConkey agar 9 could 
indicate that we are actually dealing with a  B. pseudomallei 
isolate. 
 In our case, the presence of a bilateral calf abscess in a dia-
betic patient coming from tropical Africa raised the diag-
nostic possibility of a tropical pyomyositis produced by 
 Staphylococcus aureus ; however, Gram stain results were 
unclear and an empirical therapy covering both gram-positive 
and gram-negative bacteria was started while waiting for the 
culture results. After detecting with image techniques pleural 
and splenic microabscesses and isolating a  Burkholderia from 
the pus of the calf, the possibility of a meliodiosis was first 
raised, regardless of the travel history of the patient. 
 Pneumonia is the most common clinical presentation of 
melioidosis, accounting for up to 50% of cases in most stud-
ies, followed by skin and soft tissue infections (13% to 24%), 
acute suppurative parotitis (representing in Thailand up to 
40% of pediatric cases), and genitourinary infections (18% of 
males with prostatitis in Australia). 3 Pyomyositis is a rare early 
clinical presentation in melioidosis; in a recent study from 
Thailand pyomyositis was detected in only 12 of 679 patients 
with confirmed infection. 10 
 In relation to the molecular study, it is difficult to determine 
a geographical distribution and relationship among differ-
ent ST considering the data available in the MLST database, 
as there are only a few isolates from America and Africa. 
However, the presence of ST 349 in both the Caribbean and 
West Africa is intriguing. It could be hypothesized that this 
distribution is related to the established trading posts in the 
French colonies during the 17th–19th centuries, although more 
data would be needed to corroborate it. 
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